These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1932486)

  • 1. [Apolipoproteins and atherosclerosis].
    Arribas Castrillo JM
    An Med Interna; 1991 Jul; 8(7):317-9. PubMed ID: 1932486
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic value of lipids and apolipoproteins for assessment of atherogenic risk].
    Herrmann W; Hanf S; Schütz C; Lindhofer HG; Schmidt H; Strauss HJ; Schaedel H; Oswald B
    Z Gesamte Inn Med; 1988 Feb; 43(4):86-92. PubMed ID: 3376506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the cardiovascular risk associated with atherosclerosis: HDL-cholesterol or apoproteins? (author's transl)].
    Haïat R; Bugugnani MJ
    Nouv Presse Med; 1982 Apr; 11(19):1487-9. PubMed ID: 6804931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoproteins as markers and managers of coronary risk.
    Chan DC; Watts GF
    QJM; 2006 May; 99(5):277-87. PubMed ID: 16504986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipids, lipoproteins and apolipoproteins among turks, and impact on coronary heart disease.
    Onat A
    Anadolu Kardiyol Derg; 2004 Sep; 4(3):236-45. PubMed ID: 15355827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New aspects in lipidology and atherosclerosis.
    Superko HR
    Can J Cardiol; 1995 May; 11 Suppl C():4C-8C. PubMed ID: 7750049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of exercise in modulating the impact of an ultralow-fat diet on serum lipids and apolipoproteins in patients with or at risk for coronary artery disease.
    Marshall DA; Vernalis MN; Remaley AT; Walizer EM; Scally JP; Taylor AJ
    Am Heart J; 2006 Feb; 151(2):484-91. PubMed ID: 16442919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipoprotein (a): variability and association with coronary disease].
    Souza DR; Garcia MV
    Arq Bras Cardiol; 1994 Mar; 62(3):187-94. PubMed ID: 7980082
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum HDL-cholesterol, apo-A-I and apo-E levels in patients with abnormal coronary arteries.
    Tan MH; Weldon KL; Albers JJ; Cheung MC; Havel RJ; Vigne JL
    Clin Invest Med; 1980; 3(3-4):225-32. PubMed ID: 6784991
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of lipids, lipoproteins and apolipoproteins concentrations in cord blood serum of newborns from rural and urban environments.
    Pac-Kozuchowska E
    Ann Agric Environ Med; 2007; 14(1):25-9. PubMed ID: 17655173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Apolipoproteins in atherosclerosis].
    Carino C; Rauseo R; Tiboni GM; De Martiis M
    Clin Ter; 1984 Sep; 110(5):477-82. PubMed ID: 6238762
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma lipids and coronary atherosclerosis in Japanese men.
    Nakaya Y; Hiasa Y; Morimoto S
    Tokushima J Exp Med; 1993 Dec; 40(3-4):177-82. PubMed ID: 8184414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion.
    Mendoza SG; Zerpa A; Carrasco H; Colmenares O; Rangel A; Gartside PS; Kashyap ML
    Artery; 1983; 12(1):1-23. PubMed ID: 6431945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on cholesteryl ester transfer activity in coronary heart disease.
    Fujinuma Y; Tanaka A; Maezawa H
    Bull Tokyo Med Dent Univ; 1991 Sep; 38(3):27-33. PubMed ID: 1934199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of phenobarbital on serum high density lipoprotein subfractions and apolipoproteins.
    Luoma PV; Marniemi J; Sotaniemi EA
    Res Commun Chem Pathol Pharmacol; 1988 Oct; 62(1):125-8. PubMed ID: 3144720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypocholesterolemia in myeloproliferative diseases with myelofibrosis.
    Ginsberg H; Gilbert HS
    Prog Clin Biol Res; 1984; 154():345-57. PubMed ID: 6382303
    [No Abstract]   [Full Text] [Related]  

  • 17. [Various lipoprotein fractions and their relation to ischemic heart disease].
    Palazzuoli V; Mondillo S; Kristodhullu A; De Stefano R; Amatucci G
    G Ital Cardiol; 1983; 13(2):90-4. PubMed ID: 6884650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein(a) phenotypes predict the severity of coronary artery stenosis.
    Ducas J; Silversides C; Dembinski TC; Chan MC; Tate R; Dick A; Nixon P; Ren S; Shen GX
    Clin Invest Med; 2002 Jun; 25(3):74-82. PubMed ID: 12137255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of high-density lipoproteins in the cardiology unit].
    Sampietro T; Bigazzi F; Dal Pino B; Landi P; Puntoni M; Minichilli F; Bianchi F; Chella E; Carpeggiani C; Bionda A
    Ital Heart J Suppl; 2004 Sep; 5(9):720-6. PubMed ID: 15568610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of apolipoproteins and cholesterol of low and high density lipoproteins in asymptomatic Chagas disease.
    Cano RC; Rubiolo ER; Santamarina NO
    Medicina (B Aires); 1985; 45(3):269-72. PubMed ID: 3939428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.